Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis

H Qiu1, W Zhang, A K El-Naggar

  • 1Departments of Clinical Cancer Prevention, Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

Insights

Loss of retinoic acid receptor beta (RAR-beta) expression is linked to esophageal cancer development. This early event impacts carcinogenesis and squamous differentiation in esophageal tissues.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Retinoic acid (RA) inhibits esophageal cancer cell growth.
  • This inhibition correlates with retinoic acid receptor beta (RAR-beta) expression.
  • RAR-beta expression is crucial for RA sensitivity in esophageal cancer cells.

Purpose of the Study:

  • To investigate the in vivo expression of RAR-beta mRNA in normal, dysplastic, and cancerous esophageal tissues.
  • To determine the association between RAR-beta expression and esophageal carcinogenesis.
  • To explore the relationship between RAR-beta expression and the degree of squamous differentiation.

Main Methods:

  • In situ hybridization was used to analyze RAR-beta mRNA expression.
  • Esophageal tissue specimens included normal mucosa, dysplastic lesions, and esophageal tumors (squamous cell carcinomas).
  • Expression levels were correlated with clinicopathological features, including differentiation status.

Main Results:

  • RAR-beta mRNA was detected in 88% of normal esophageal tissues and 96% of adjacent normal mucosa.
  • Expression was significantly lower in dysplastic lesions (57%) and carcinomas (54%).
  • RAR-beta expression decreased with poor squamous cell carcinoma differentiation (29% in poorly differentiated vs. 62% in well-differentiated).

Conclusions:

  • Loss of RAR-beta expression is an early event in esophageal carcinogenesis.
  • Reduced RAR-beta expression is associated with decreased squamous differentiation in esophageal tumors.
  • RAR-beta may serve as a biomarker for esophageal cancer progression.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...